About US Oncology - Comprehensive Cancer Centers of Nevada (CCCN)
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
AVEO Pharmaceuticals, Inc.
1
Ipsen
1
Clinical Trials at US Oncology - Comprehensive Cancer Centers of Nevada (CCCN)
During the past decade, US Oncology - Comprehensive Cancer Centers of Nevada (CCCN) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 1 clinical trials were completed, i.e. on
average, 50% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens Versus Nab-paclitaxel Plus Gemcitabine in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma
2015-10-19
2021-02-15
Completed
56
Study to Compare Tivozanib in Combination With Nivolumab to Tivozanib Monotherapy in Subjects With Renal Cell Carcinoma
2021-09-09
2025-08-01
Recruiting
326
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "US Oncology - Comprehensive Cancer Centers of Nevada (CCCN)"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator and "Parexel" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at US Oncology - Comprehensive Cancer Centers of Nevada (CCCN)
According to Clinical.Site data, the most researched conditions in "US Oncology - Comprehensive Cancer Centers of Nevada (CCCN)" are
"Pancreatic Cancer" (1 trials) and "Renal Cell Carcinoma" (1 trials). Many other conditions were trialed in "US Oncology - Comprehensive Cancer Centers of Nevada (CCCN)" in a lesser frequency.
Clinical Trials Intervention Types at US Oncology - Comprehensive Cancer Centers of Nevada (CCCN)
Most popular intervention types in "US Oncology - Comprehensive Cancer Centers of Nevada (CCCN)" are "Drug" (2 trials). Other intervention types were less common.
The name of intervention was led by "5 fluorouracil" (1 trials), "Leucovorin" (1 trials), "Nivolumab" (1 trials), "Oxaliplatin" (1 trials) and "Tivozanib" (1 trials). Other intervention names were less common.
Clinical Trials Genders at US Oncology - Comprehensive Cancer Centers of Nevada (CCCN)
The vast majority of trials in "US Oncology - Comprehensive Cancer Centers of Nevada (CCCN)" are
2 trials for "All" genders.
Clinical Trials Status at US Oncology - Comprehensive Cancer Centers of Nevada (CCCN)
Currently, there are NaN active trials in "US Oncology - Comprehensive Cancer Centers of Nevada (CCCN)".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in US Oncology - Comprehensive Cancer Centers of Nevada (CCCN),
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in US Oncology - Comprehensive Cancer Centers of Nevada (CCCN), 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".